RO7239361 (BMS-986089) ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	2

113. Muscular dystrophy

Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-001654-18-BE (EUCTR)	10/11/2017	26/06/2017	Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 (BMS-986089)in Ambula ...	A randomized, double blind, placebo-controlled, study to assess the efficacy, safety, and tolerabili ...	Duchenne Muscular Dystrophy MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: Duchen ...	Product Name: BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL) Product Code: RO72393 ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: no Male: yes	159	Phase 3	United States;Spain;Italy;United Kingdom;France;Canada;Argentina;Belgium;Australia;Germany;Netherlan ...
2	NCT02515669 (ClinicalTrials.gov)	December 2, 2015	29/7/2015	Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD	A Multi-Site, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Subcutaneous Dose Stu ...	Muscular Dystrophy (DMD)	Drug: RO7239361;Drug: Placebo	Hoffmann-La Roche	NULL	Terminated	5 Years	10 Years	Male	43	Phase 1/Phase 2	United States;Canada

First Previous1Next Last